Skip to search formSkip to main contentSkip to account menu

SCYX 7158

Known as: SCYX-7158, SCYX7158 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

BenzamidesBoron Compounds

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Optimal kinetic exposures for classic and candidate antitrypanosomals.
OBJECTIVES Efficacy is determined not only by size, but also by shape, of drug exposure. Here the critical importance of the… 
2018
2018
Heterogeneity in the in vitro susceptibility of Loa loa microfilariae to drugs commonly used in parasitological infections
Co-infection with loiasis remains a potential problem in control programs targeting filarial infections. The effects of many anti… 
2009
2009
Efficacy and Pharmacokinetics of SCYX-7158 (AN5568): a Novel and Potent Oxaborole-6-Carboxamide Selected as a Pre-Clinical Candidate for Once-Daily Oral Treatment for Stage 2 Human African…
In vitro activity against Trypanosoma brucei strains Summary SCYX-7158, a 3,3-dimethyloxaborole-6-carboxamide, is distinguished… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)